Literature DB >> 17101648

Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.

Michael J Flagler1, Jane E Strasser, Claudia L Chalk, Alison A Weiss.   

Abstract

Hemolytic-uremic syndrome (HUS), the life-threatening complication following infection by the intestinal pathogen Escherichia coli O157:H7, is due to the ability of the pathogen to produce toxins in the Shiga toxin (Stx) family. Activated neutrophils are observed in HUS patients, yet it is unclear whether Stx exerts a direct effect on neutrophils or whether the toxin acts indirectly. The effect of Stx1 and Stx2 on human neutrophils was examined. Neither Stx1 nor Stx2 altered the rate of neutrophil apoptosis. Minimal binding of either toxin to neutrophils was observed, and the toxin was easily eluted from the cells. Stx1 and Stx2 were found to circulate in the plasma of mice following intravenous injection, and both toxins were cleared rapidly from the blood. Together these results suggest that neither Stx1 nor Stx2 interacts directly with neutrophils.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101648      PMCID: PMC1828505          DOI: 10.1128/IAI.01594-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Role of medullasin in granulocytes in the development of inflammation. I. Phlogistic activity and the effect on functions of macrophages and granulocytes.

Authors:  Y Aoki; R Machinami
Journal:  Arthritis Rheum       Date:  1983-08

2.  Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells.

Authors:  Andreas Matussek; Joerg Lauber; Anna Bergau; Wiebke Hansen; Manfred Rohde; Kurt E J Dittmar; Matthias Gunzer; Michael Mengel; Patricia Gatzlaff; Maike Hartmann; Jan Buer; Florian Gunzer
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

3.  Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

Authors:  A D O'Brien; J W Newland; S F Miller; R K Holmes; H W Smith; S B Formal
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

4.  Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.

Authors:  Richard L Siegler; Tom G Obrig; Theodore J Pysher; Vernon L Tesh; Nathaniel D Denkers; Fletcher B Taylor
Journal:  Pediatr Nephrol       Date:  2003-01-10       Impact factor: 3.714

5.  Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.

Authors:  Pier Luigi Tazzari; Francesca Ricci; Domenica Carnicelli; Alfredo Caprioli; Alberto E Tozzi; Gianfranco Rizzoni; Roberto Conte; Maurizio Brigotti
Journal:  Cytometry B Clin Cytom       Date:  2004-09       Impact factor: 3.058

6.  Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils.

Authors:  B A Macher; J C Klock
Journal:  J Biol Chem       Date:  1980-03-10       Impact factor: 5.157

7.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

8.  Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells.

Authors:  M N Fukuda; A Dell; J E Oates; P Wu; J C Klock; M Fukuda
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

9.  Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2.

Authors:  Shantini D Gamage; Colleen M McGannon; Alison A Weiss
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

10.  Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.

Authors:  A Donohue-Rolfe; G T Keusch; C Edson; D Thorley-Lawson; M Jacewicz
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  10 in total

1.  Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Valentina Arfilli; Laura Rocchi; Francesca Ricci; Pasqualepaolo Pagliaro; Pier Luigi Tazzari; Antonio González Vara; Matteo Amelia; Francesco Manoli; Sandra Monti
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

Review 2.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

Review 3.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

4.  Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome.

Authors:  Maria Victoria Ramos; Maria Pilar Mejias; Florencia Sabbione; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Maria Marta Amaral; Ramon Exeni; Analia Silvina Trevani; Marina Sandra Palermo
Journal:  J Innate Immun       Date:  2016-05-28       Impact factor: 7.349

5.  Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.

Authors:  Ivan U Kouzel; Gottfried Pohlentz; Wiebke Storck; Lena Radamm; Petra Hoffmann; Martina Bielaszewska; Andreas Bauwens; Christoph Cichon; M Alexander Schmidt; Michael Mormann; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2012-12-17       Impact factor: 5.922

Review 6.  The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?

Authors:  Maurizio Brigotti
Journal:  Toxins (Basel)       Date:  2012-03-01       Impact factor: 4.546

7.  Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases.

Authors:  Paola Neri; Shunji Tokoro; Ryo Kobayashi; Tsuyoshi Sugiyama; Kouji Umeda; Takeshi Shimizu; Takao Tsuji; Yoshikatsu Kodama; Keiji Oguma; Hiroshi Mori
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  LPS-primed CD11b+ leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice.

Authors:  Shuo Niu; John Paluszynski; Zhen Bian; Lei Shi; Koby Kidder; Yuan Liu
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

Review 9.  Verotoxin Receptor-Based Pathology and Therapies.

Authors:  Clifford Lingwood
Journal:  Front Cell Infect Microbiol       Date:  2020-03-31       Impact factor: 5.293

Review 10.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.

Authors:  Adrien Joseph; Aurélie Cointe; Patricia Mariani Kurkdjian; Cédric Rafat; Alexandre Hertig
Journal:  Toxins (Basel)       Date:  2020-01-21       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.